Search
Cardiolipin Biosynthesis CL(a-15:0/i-18:0/a-21:0/a-25:0)
smpdb.ca/view/SMP0461260MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-15:0/i-18:0/a-25:0/a-25:0)
smpdb.ca/view/SMP0461282MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-15:0/i-19:0/a-25:0/a-25:0)
smpdb.ca/view/SMP0470112MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-15:0/i-22:0/a-25:0/a-25:0)
smpdb.ca/view/SMP0490176MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Atropine
go.drugbank.com/drugs/DB00572ApprovedInvestigationalVet approvedAtropine is an alkaloid originally synthesized from Atropa belladonna. It is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active. … [A251670,L42835] Atropine is generally available as a sulfate salt and can be administered by intravenous, subcutaneous, intramuscular, intraosseous, endotracheal and ophthalmic methods.
Mixtures: PHARMANIAGA DIPHENOXYLATE A TABLET, B-DonnaCategories: P-glycoprotein substratesCardiolipin Biosynthesis CL(a-13:0/a-13:0/a-13:0/i-12:0)
smpdb.ca/view/SMP0043668DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-13:0/i-16:0)
smpdb.ca/view/SMP0043672DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-13:0/i-20:0)
smpdb.ca/view/SMP0043676DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-15:0/i-12:0)
smpdb.ca/view/SMP0043686DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/a-13:0/a-15:0/i-16:0)
smpdb.ca/view/SMP0043689DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.